Medical News

RSS

JDRF, Amylin collaborate to support metreleptin study for type 1 diabetes

The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.

17 Nov 2010

MedAssets acquires The Broadlane Group

MedAssets, Inc. today announced that it has completed its acquisition of The Broadlane Group. The combination of MedAssets and Broadlane creates the industry's leading, end-to-end financial improvement partner that has saved billions for its healthcare provider customers, including more than $2.8 billion in documented and guaranteed supply chain savings.

17 Nov 2010

Medicare roundup: Payment cuts irk healthcare industry; officials mull new prostate-cancer treatment

Doctors across the United States are taking a wait-and-see approach while Congress decides whether or not to allow a scheduled 23% cut in Medicare reimbursement rates to take effect on Dec. 1.

17 Nov 2010

Researchers explore interplay between pain and anxiety

Disability from chronic pain in adolescents can be exacerbated by high levels of anxiety, according to research reported The Journal of Pain, the peer review publication of the American Pain Society.

17 Nov 2010

Study: EGFR inhibtion may help treat triple negative breast cancer

Scientists believe they may have found a new target for treating triple negative breast cancer - one of the more difficult breast cancers to treat successfully and for which there is no targeted therapy at present.

17 Nov 2010

Swissmedic approves use of plasma components treated with Cerus' INTERCEPT Blood System

Cerus Corporation announced today that the Swiss regulatory body, Swissmedic, has approved the use of plasma components treated with Cerus' INTERCEPT Blood System.

17 Nov 2010

Officials look to 2 states for advice on setting up exchanges; other health overhaul news

Two states Massachusetts and Utah are forerunners in establishing health insurance exchanges, a key part of the health overhaul, and are likely to serve as models for other states, Politico reports.

17 Nov 2010

UMass, PolyMedix receive Phase 2 STTR contract to conduct test on antimicrobial compounds

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, and the University of Massachusetts, Amherst (UMass), have received a Phase 2 Small Business Technology Transfer (STTR) contract in the amount of $750,000.

17 Nov 2010

New safety reporting website for electronic health records launched

The Wall Street Journal: An alliance of executives from medical societies and professional liability carriers yesterday launched "EHRevent.org, a new safety reporting system for [electronic health records] EHRs. Doctors and other health-care workers can go online and report problems and mistakes they experience as they ramp up the use of digitized records.

17 Nov 2010

Stratatech receives SBIR grant to develop anti-infective living human skin substitute

Stratatech Corp., a privately-held regenerative medicine company, today announced that it has been awarded a $3.5 million Fast-Track SBIR grant to expand the development of its anti-infective living human skin substitute.

17 Nov 2010

AVEO commences enrollment in Phase 1b combination trial of tivozanib with oral capecitabine in advanced tumors

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated patient enrollment in an open-label, multi-center Phase 1b clinical trial evaluating tivozanib in combination with oral capecitabine (Xeloda®) in patients with certain advanced solid tumors.

17 Nov 2010

Avedro's KXL System for corneal cross-linking granted European CE Mark

Avedro, Inc., sponsor of two completed US FDA multi-center clinical trials for corneal cross-linking, today announced that its KXL™ System for performing accelerated corneal cross-linking (KXL) has received the European Union's CE Mark. The CE Mark certifies that the KXL System has met the EU's health and safety standards and opens the door to immediate commercialization across the European Economic Community and in other countries recognizing the CE Mark.

17 Nov 2010

Berwick to testify for the first time as Medicare/Medicaid chief

Medicare and Medicaid chief Donald Berwick will testify before a congressional committee Wednesday for the first time since President Barack Obama avoided the Senate confirmation process to Republican protest by using a recess appointment to install Berwick as the administrator of the Center for Medicare and Medicaid Services.

17 Nov 2010

ALLOZYNE's AZ17 antagonist shows positive data for treatment of autoimmune diseases

ALLOZYNE Inc. announced today positive data from preclinical studies evaluating AZ17 which is a novel bispecific Th17 antagonist that inhibits the differentiation and effector function of human Th17 cells in vivo.

17 Nov 2010

Progenics initiates ONO-3849 phase 2 clinical trial for OIC in Japan

Progenics Pharmaceuticals, Inc. today announced the initiation of a phase 2 clinical trial of subcutaneous methylnaltrexone in Japan by its collaborator, Ono Pharmaceutical Co., Ltd. The drug, designated ONO-3849 in Japan, is being evaluated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness such as cancer.

17 Nov 2010

Changes to flexible spending accounts; High co-pays prompt abandoned prescriptions

Minnesota Public Radio: "[T]he federal health care reform law is cutting back on what [flexible spending] accounts will cover and how much workers can put into them. … These two changes are designed to raise more tax revenue to help pay for insuring another 32 million Americans beginning in 2014.

16 Nov 2010

Regional U.N. meeting explores African development

Africa has the potential to expand development with the help of international support and stability, Asha-Rose Migiro, U.N. deputy secretary general, said on Sunday at the opening of the 11th Regional Coordination Mechanism (RCM) meeting in Addis Ababa, Ethiopia, Next reports.

16 Nov 2010

Neurologic complications remain an important cause of morbidity and mortality after heart surgeries

Strokes, seizures and other neurological complications related to heart surgery account for "considerable morbidity and mortality," Loyola University Health System neurologists report in the November issue of the journal Hospital Practice.

16 Nov 2010

Optivia, UCSF receive SBIR grant to develop transporter-based assay system

Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced that the company and the University of California, San Francisco (UCSF), have received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to develop an innovative system for characterizing the role transporter proteins play in the disposition of drugs by the liver.

16 Nov 2010

AEDs do not improve rate of survival for in-hospital cardiac arrests

While automated external defibrillators improve survival for out-of-hospital cardiac arrest, an analysis of data indicates their use for cardiac arrest in a hospital does not result in an improved rate of survival, according to a study in the November 17 issue of JAMA. The study is being released early online because it will be presented at the American Heart Association's annual meeting.

16 Nov 2010

Medical News

JDRF, Amylin collaborate to support metreleptin study for type 1 diabetes

MedAssets acquires The Broadlane Group

Medicare roundup: Payment cuts irk healthcare industry; officials mull new prostate-cancer treatment

Researchers explore interplay between pain and anxiety

Study: EGFR inhibtion may help treat triple negative breast cancer

Swissmedic approves use of plasma components treated with Cerus' INTERCEPT Blood System

Officials look to 2 states for advice on setting up exchanges; other health overhaul news

UMass, PolyMedix receive Phase 2 STTR contract to conduct test on antimicrobial compounds

New safety reporting website for electronic health records launched

Stratatech receives SBIR grant to develop anti-infective living human skin substitute

AVEO commences enrollment in Phase 1b combination trial of tivozanib with oral capecitabine in advanced tumors

Avedro's KXL System for corneal cross-linking granted European CE Mark

Berwick to testify for the first time as Medicare/Medicaid chief

ALLOZYNE's AZ17 antagonist shows positive data for treatment of autoimmune diseases

Progenics initiates ONO-3849 phase 2 clinical trial for OIC in Japan

Changes to flexible spending accounts; High co-pays prompt abandoned prescriptions

Regional U.N. meeting explores African development

Neurologic complications remain an important cause of morbidity and mortality after heart surgeries

Optivia, UCSF receive SBIR grant to develop transporter-based assay system

AEDs do not improve rate of survival for in-hospital cardiac arrests

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

Latest News